The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: Pronounced benefits in African-Americans and hypertensives

Preventive Medicine

Volumn 37, Issue 4, 2003, Pages 327-333

  Erlinger, Thomas P ^a,b,e   Vollmer, William M ^c   Svetkey, Laura P ^d   Appel, Lawrence J ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c KAISER PERMANENTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

African American; Blood pressure; Coronary heart disease; Dietary Approaches to Stop Hypertension (DASH); Hypertension; National Health and Nutrition Examination Survey (NHANES)

Indexed keywords

ARTICLE; BLOOD PRESSURE REGULATION; COMPARATIVE STUDY; CORONARY RISK; DATA ANALYSIS; DIETARY INTAKE; HEALTH SURVEY; HEART PROTECTION; ISCHEMIC HEART DISEASE; NEGRO; POPULATION MODEL; POPULATION RESEARCH; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0141514638     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-7435(03)00140-3     Document Type: Article

References (23)

1. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure prospective observational studies corrected for the regression dilution bias . Lancet. 335:1990;765-774.
2. Stamler J., Stamler R., Neaton J.D. Blood pressure, systolic and diastolic, and cardiovascular risks US population data . Arch Intern Med. 153:1993;598-615.
3. Rose G. Strategy of prevention lessons from cardiovascular disease . Br Med J (Clin Res Ed). 282:1981;1847-1851.
4. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
5. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 336:1997;1117-1124.
6. Giumetti D., Liu K., Stamler R., Schoenberger J.A., Shekelle R.B., Stamler J. Need to prevent and control high normal and high blood pressure, particularly so-called "mild" hypertension epidemiological and clinical data . Prev Med. 14:1985;396-412.
7. Rose G. The strategy of preventive medicine. 1992;Oxford Univ. Press, London/New York.
8. Cook N.R., Cohen J., Hebert P.R., Taylor J.O., Hennekens C.H. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 155:1995;701-709.
9. Klag M.J., Whelton P.K., Appel L.J. Effect of age on the efficacy of blood pressure treatment strategies. Hypertension. 16:1990;700-705.
10. Whelton P.K., He J., Cutler J.A., Brancati F.L., Appel L.J., Follmann D., et al. Effects of oral potassium on blood pressure meta-analysis of randomized controlled clinical trials . JAMA. 277:1997;1624-1632.
11. Law M.R., Frost C.D., Wald N.J. By how much does dietary salt reduction lower blood pressure? I. Analysis of observational data among populations. BMJ. 302:1991;811-815.
12. Frost C.D., Law M.R., Wald N.J. By how much does dietary salt reduction lower blood pressure? II. Analysis of observational data within populations. BMJ. 302:1991;815-818.
13. Law M.R., Frost C.D., Wald N.J. By how much does dietary salt reduction lower blood pressure? III. Analysis of data from trials of salt reduction. BMJ. 302:1991;819-824.
14. Svetkey L.P., Simons-Morton D., Vollmer W.M., Appel L.J., Conlin P.R., Ryan D.H., et al. Effects of dietary patterns on blood pressure subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial . Arch Intern Med. 159:1999;285-293.
15. Vollmer W.M., Sacks F.M., Ard J., Appel L.J., Bray G.A., Simons-Morton D.G., et al. Effects of diet and sodium intake on blood pressure subgroup analysis of the DASH-sodium trial . Ann Intern Med. 135:2001;1019-1028.
16. Ezzati T.M., Massey J.T., Waksberg J., Chu A., Maurer K.R. Sample design Third National Health and Nutrition Examination Survey . Vital Health Stat 2. 113:1992;1-35.
17. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., et al. Prevalence of hypertension in the US adult population results from the Third National Health and Nutrition Examination Survey, 1988-1991 . Hypertension. 25:1995;305-313.
18. Anderson K.M., Wilson P.W., Odell P.M., Kannel W.B. An updated coronary risk profile a statement for health professionals . Circulation. 83:1991;356-362.
19. Gordon T., Kannel W. Premature mortality from coronary heart disease the Framingham study . JAMA. 215:1971;1617-1625.
20. Brown D.W., Giles W.H., Croft J.B. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J. 140:2000;848-856.
21. Leaverton P.E., Sorlie P.D., Kleinman J.C., Dannenberg A.L., Ingster-Moore L., Kannel W.B., et al. Representativeness of the Framingham risk model for coronary heart disease mortality a comparison with a national cohort study . J Chronic Dis. 40:1987;775-784.
22. Liao Y., McGee D.L., Cooper R.S., Sutkowski M.B. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J. 137:1999;837-845.
23. Liao Y., McGee D.L., Cooper R.S. Prediction of coronary heart disease mortality in blacks and whites pooled data from two national cohorts . Am J Cardiol. 84:1999;31-36.